RedDress Ltd. is a private medical device company that has developed a groundbreaking, advanced wound care product based on patented technology to reproduce the natural process of the body to heal wounds. Founded in 2010 by Dr. Igal Kushnir, MD and Alon Kushnir, the company is based in Israel and focused on developing effective solutions that improve outcomes for patients. RedDress management boasts vast experience in bringing breakthrough medical ideas to successful commercialization in the Biotechnology and Health Care industries. Their latest achievement includes a $26.00M Series D investment on 24 May 2023, led by HCS Capital Partners, Athos Therapeutics, and Ragnar. With their innovative approach to addressing unmet medical needs, RedDress is well-positioned for continued success.
No recent news or press coverage available for RedDress Ltd..